Drug Shortage Report for AVAPRO

Last updated on 2019-02-27 History
Report ID 68058
Drug Identification Number 02237923
Brand name AVAPRO
Common or Proper name Avapro RM 75mg
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) IRBESARTAN
Strength(s) 75MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 90
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Other (Please describe in comments)
Anticipated start date 2018-12-14
Actual start date
Estimated end date 2019-02-28
Actual end date 2019-02-26
Shortage status Resolved
Updated date 2019-02-27
Company comments The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2019-02-27 English Compare
v12 2019-02-26 French Compare
v11 2019-02-26 English Compare
v10 2019-02-26 English Compare
v9 2019-01-30 French Compare
v8 2019-01-30 English Compare
v7 2018-12-20 French Compare
v6 2018-12-20 English Compare
v5 2018-12-15 English Compare
v4 2018-11-29 French Compare
v3 2018-11-29 English Compare
v2 2018-11-29 French Compare
v1 2018-11-29 English Compare

Showing 1 to 13 of 13